Venmax Drugs & Pharmaceuticals

Venmax Drugs & Pharmaceuticals

31.60
+2.49
(8.55%)
Market Cap
15.30 Cr
EPS
-0.02
PE Ratio
11.00
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
31.95
52 Week Low
6.27
PB Ratio
3.47
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,641.80
#1 3,93,538.90
34.30
#1 54,729.00
9.71
#1 10,980
-19.84
47.84
6,151.50
1,60,024.50
69.37
9,712.00
18.67
2,191
26.74
42.63
1,592.80
1,28,651.70
23.86
28,409.50
7.12
5,291
9.88
66.07
3,685.30
1,23,444.60
61.13
11,539.40
6.99
1,911
19.91
62.55
2,606.80
1,07,313.60
56.78
12,744.20
#1 20.90
2,007
-18.14
60.80
1,277.60
1,06,541.30
#1 18.75
33,741.20
16.73
5,725
1.26
57.55
988.80
99,194.50
21.29
23,511.00
18.55
4,615
2.60
57.27
1,974.70
89,626.50
24.22
22,909.50
13.74
3,306
#1 51.64
55.21
31,875.00
69,347.10
47.71
6,684.70
9.64
1,414
11.55
39.14
5,426.00
64,828.10
28.51
13,458.30
3.70
2,216
21.39
70.80
Forecast
Actual
Growth Rate
Revenue Growth
-50.00 %
Net Income Growth
-50.00 %
Cash Flow Change
-100.00 %
ROE
-68.58 %
ROCE
-57.67 %
EBITDA Margin (Avg.)
-15.03 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
2
2
0
0
0
1
0
2
0
0
1
3
Expenses
3
2
1
0
0
1
1
0
0
0
2
3
EBITDA
-0
-0
-1
-0
-0
-0
-0
2
0
0
-1
0
Operating Profit %
-5 %
-7 %
-238 %
0 %
-158 %
-54 %
-198 %
0 %
0 %
0 %
-131 %
-124 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-0
-0
-1
-0
-0
-0
-0
2
0
0
-0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
-0
-0
-1
-0
-0
-0
-0
2
0
0
-0
0
EPS in ₹
-0.15
-0.26
-2.55
-0.46
-0.45
-0.52
-0.31
3.52
0.43
0.12
-0.02
0.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
4
3
0
0
0
1
0
0
0
0
5
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
Current Assets
2
1
0
0
0
0
0
0
0
0
5
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
4
3
0
0
0
0
0
0
0
0
0
Total Liabilities
4
3
0
0
0
1
0
0
0
0
5
Current Liabilities
2
1
2
2
3
3
3
1
1
1
1
Non Current Liabilities
2
2
0
0
0
0
0
0
0
0
0
Total Equity
0
0
-2
-2
-2
-3
-3
-1
-1
-1
4
Reserve & Surplus
-5
-5
-7
-7
-8
-8
-8
-6
-6
-6
-1
Share Capital
5
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Cash Flow
0
0
0
0
0
0
0
-0
0
Investing Activities
0
0
0
0
-0
0
0
0
0
Operating Activities
-0
-0
-1
-0
-0
-0
0
2
0
Financing Activities
0
0
1
0
0
0
-0
-2
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
23.14 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
65.69 %
65.69 %
65.57 %
65.57 %
65.57 %
65.57 %
65.64 %
65.64 %
65.64 %
65.66 %
65.66 %
65.66 %
65.66 %
65.66 %
65.67 %
65.54 %
65.24 %
65.01 %
Others
11.03 %
11.03 %
11.15 %
11.15 %
11.15 %
11.15 %
11.07 %
11.07 %
11.07 %
11.06 %
11.06 %
11.06 %
11.06 %
11.06 %
11.04 %
11.17 %
11.47 %
11.86 %
No of Share Holders
0
6,261
6,261
6,257
6,256
6,255
6,255
6,253
6,251
6,250
6,250
6,252
6,251
6,252
6,291
6,657
6,756
6,729

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 4.18 4.18
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 4.18 4.18
06 Feb 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
06 Feb 2025 21.71 30.27
08 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Feb 2025 29.69 29.08
09 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 May 2025 27.90 28.17
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jul 2025 24.81 28.04

Announcements

Board Meeting Outcome for Outcome Of Board Meeting For Conversion Of Share Warrants And Allotment Of Equity Shares6 days ago
Board Meeting Intimation for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Equity Share Warrants.Aug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Financial Results For The Quarter Ended June 30 2025.Jul 23, 2025
Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2025.Jul 23, 2025
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025.Jul 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 10, 2025
Integrated Filing (Financial)May 09, 2025
Audited Financial Results March 31St 2025.May 09, 2025
Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended March 31St 2025.May 09, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AMay 05, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 05, 2025
Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Year And Quarter Ended 31St March 2025.May 01, 2025
Change In Key ManagementApr 26, 2025
Resignation Of Ms. Pratibha Jhawar From The Post Of Company Secretary & Compliance OfficerApr 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Closure of Trading WindowMar 28, 2025
Board Meeting Outcome for Allotment Of Equity Share Warrants.Mar 21, 2025
Integrated Filing (Financial)Feb 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2025
Board Meeting Outcome for Financial Results For The Quarter And Nine Months Ended 31.12.2024.Feb 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMFeb 06, 2025
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31St December 2024.Feb 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2025
We Would Like To Inform You That The Extra-Ordinary General Meeting Is Schedule To Be Held On Thursday February 06 2025 At 12:00 PM Through Video Conferencing Or Other Audio Visual Means ("OAVM").Jan 13, 2025
Board Meeting Outcome for Outcome Of The Board MeetingJan 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Board Meeting Intimation for Increase In Authorised Capital And Fund Raising Proposal.Jan 06, 2025
Closure of Trading WindowDec 31, 2024
Announcement under Regulation 30 (LODR)-CessationDec 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2024
Board Meeting Outcome for Outcome Of Board MeetingNov 11, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On November 11, 2024Oct 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementOct 01, 2024
Refiling Of Financial Results For The Quarter Ended 30.06.2024.Sep 30, 2024
Closure of Trading WindowSep 26, 2024
Submission Of E-Voting Results And Scrutinizer ReportSep 23, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 21, 2024
Refiling Of Financial Results For The Quarter Ended 30.06.2023Sep 17, 2024
Refiling Of Financial Results For The Quarter Ended 30.09.2023Sep 16, 2024
Refiling Of Financial Results For The Quarter Ended 31.12.2023Sep 16, 2024
Refiling Of Financial Results For The Quarter And Year Ended 31.03.2024.Sep 16, 2024
Refiling Of Financial Results For The Quarter And Year Ended 31.03.2024.Sep 16, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 10, 2024
Intimation Of Appointment Of Company Secretary And Compliance OfficerSep 02, 2024
Reg. 34 (1) Annual Report.Aug 23, 2024

Technical Indicators

RSI(14)
Neutral
66.38
ATR(14)
Less Volatile
2.36
STOCH(9,6)
Neutral
61.01
STOCH RSI(14)
Overbought
87.93
MACD(12,26)
Bullish
0.18
ADX(14)
Weak Trend
18.30
UO(9)
Bearish
54.78
ROC(12)
Uptrend And Accelerating
19.44
WillR(14)
Overbought
-10.72